SCHEMBL24654099

SCHEMBL24654099

Oc1ccccc1[C@]1(C(F)(F)F)CCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 10/20 0.41
TXNRD1 Q16881 1/20 0.34
TXNRD3 Q86VQ6 1/20 0.34
TXNRD2 Q9NNW7 1/20 0.34
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HSD17B10 Q99714 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CA12 O43570 1/20 0.32
GMNN O75496 1/20 0.32
ALDH1A1 P00352 1/20 0.32
EGFR P00533 1/20 0.32
CA2 P00918 1/20 0.32
LMNA P02545 1/20 0.32
FYN P06241 1/20 0.32
POLB P06746 1/20 0.32
CA3 P07451 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24653826 1.00 PDK2 (0.41) PDK2TXNRD1TXNRD3TXNRD2NPC1
SCHEMBL19205328 0.72 PDK2 (0.46) PDK2NPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL24654103 0.70 OPRD1 (0.41) HSD17B10CA12ALDH1A1CA2LMNA
SCHEMBL24653825 0.70 HPGD (0.38) TXNRD1TXNRD3TXNRD2NPC1RAB9A
SCHEMBL12958387 0.69 IDO1 (0.37) PDK2NFKB1
SCHEMBL9837054 0.66 ALDH1A1 (0.45) PDK2NPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL2046462 0.65 ALDH1A1 (0.43) PDK2NPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL10515528 0.65 ALDH1A1 (0.43) PDK2NPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL23576911 0.64 MGLL (0.41) CA2CA4CA5ACA14CA5B
SCHEMBL3159717 0.64 MGLL (0.39) PDK2TXNRD1TXNRD3TXNRD2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4095134-A1 POLYCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL INDICATIONS UCL Business Ltd (GB) 2022-11-30 EP disclosed